General Information
Version
6.8
Revision date
2024-01-12
Product name
1,6-Dichlorohexane
CAS No.
2163-00-0
REACH No
is
Emergency telephone
+(47)-22591300, +(47)-21930678
Icons in SDS
Company Information
company name
Merck Life Science AS
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H304, H315, H411
Hazard statements
Code
Statements
H304
May be fatal if swallowed and enters airways
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Skin irritation, (Category 2) H315: Causes skin irritation. Aspiration hazard, (Category 1) H304: May be fatal if swallowed and enters airways. Long-term (chronic) aquatic H411: Toxic to aquatic life with long lasting hazard, (Category 2) effects.
2.2 Label elements
Labelling
Signal word
Danger Danger
Hazard statements
H304 May be fatal if swallowed and enters airways. H315 Causes skin irritation. H411 Toxic to aquatic life with long lasting effects. Reduced Labeling (<= 125 ml) H304 May be fatal if swallowed and enters airways.
Precautionary statements
P273 Avoid release to the environment. P301 + P310 + P331 IF SWALLOWED: Immediately call a POISON CENTER/doctor. Do NOT induce vomiting. P302 + P352 IF ON SKIN: Wash with plenty of water. P301 + P310 + P331 IF SWALLOWED: Immediately call a POISON CENTER/doctor. Do NOT induce vomiting.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.